US Stock MarketDetailed Quotes

LTRN Lantern Pharma

Watchlist
  • 3.950
  • -0.040-1.00%
Close Feb 28 16:00 ET
  • 3.890
  • -0.060-1.52%
Post 20:01 ET
42.60MMarket Cap-2.22P/E (TTM)

Lantern Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-54.54%-5.58M
-44.51%-5.19M
18.33%-3.07M
-12.37%-14.35M
-26.85%-3.39M
10.55%-3.61M
-31.45%-3.59M
-12.90%-3.76M
-20.54%-12.77M
-30.89%-2.67M
Net income from continuing operations
-42.52%-4.51M
-4.49%-4.96M
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
Operating gains losses
-184.03%-79.8K
-259.88%-56.58K
31.66%100.27K
-32.09%127.34K
-66.63%-79.17K
-22.38%94.96K
-73.75%35.39K
444.43%76.15K
272.83%187.52K
-6,671.09%-47.51K
Depreciation and amortization
18.27%4.39K
21.28%4.26K
18.81%4.06K
44.98%14.62K
44.02%3.98K
25.92%3.71K
47.21%3.51K
71.85%3.42K
49.11%10.08K
38.62%2.76K
Other non cash items
9.73%43.47K
4.38%42.01K
2.65%41.08K
10.81%160.23K
11.60%40.34K
9.58%39.61K
11.34%40.25K
10.72%40.03K
59.50%144.6K
-47.69%36.15K
Change In working capital
-17.19%-914.35K
-144.40%-301.64K
986.56%2.13M
187.93%538.02K
131.17%879.22K
67.15%-780.24K
-39.32%679.39K
-191.16%-240.35K
-201.98%-611.86K
-61.08%380.34K
-Change in prepaid assets
523.89%168.21K
-271.55%-913.95K
865.92%901.02K
191.06%941.44K
-31.22%499.36K
113.63%26.96K
147.49%532.75K
73.27%-117.64K
-5.01%-1.03M
247.92%726.03K
-Change in payables and accrued expense
-34.57%-1.03M
269.22%661.18K
1,988.12%1.27M
-140.70%-236.18K
237.39%419.92K
64.08%-767.87K
-92.15%179.07K
-109.06%-67.3K
-64.22%580.36K
-120.54%-305.64K
-Change in other current assets
---4.72K
-186.56%-6.15K
--0
---7.98K
--0
--0
--7.1K
---15.08K
--0
--0
-Change in other current liabilities
-13.17%-44.51K
-8.08%-42.73K
-1.38%-40.89K
-0.54%-159.26K
-0.02%-40.06K
1.81%-39.33K
0.16%-39.54K
-4.22%-40.33K
-121.06%-158.4K
44.11%-40.05K
Cash from discontinued investing activities
Operating cash flow
-54.54%-5.58M
-44.51%-5.19M
18.33%-3.07M
-12.37%-14.35M
-26.85%-3.39M
10.55%-3.61M
-31.45%-3.59M
-12.90%-3.76M
-20.54%-12.77M
-30.89%-2.67M
Investing cash flow
Cash flow from continuing investing activities
193.60%680.35K
55.81%-202.06K
42.12%-556.17K
-618.89%-930.21K
-57.51%256.18K
411.61%231.73K
13.03%-457.24K
-644.35%-960.88K
100.92%179.27K
357.68%602.86K
Net PPE purchase and sale
36.61%-3.03K
---4.27K
75.02%-2.22K
32.72%-18.73K
26.94%-5.08K
28.82%-4.78K
--0
---8.88K
-79.65%-27.84K
-695,400.00%-6.96K
Net investment purchase and sale
188.95%683.37K
56.74%-197.8K
41.81%-553.95K
-540.09%-911.48K
-57.16%261.26K
449.59%236.51K
10.62%-457.24K
-639.32%-952K
101.06%207.11K
360.65%609.82K
Cash from discontinued investing activities
Investing cash flow
193.60%680.35K
55.81%-202.06K
42.12%-556.17K
-618.89%-930.21K
-57.51%256.18K
411.61%231.73K
13.03%-457.24K
-644.35%-960.88K
100.92%179.27K
357.68%602.86K
Financing cash flow
Cash flow from continuing financing activities
11.99K
0
54.72K
77.09%-500K
-500K
0
0
0
-103.44%-2.18M
0
Net common stock issuance
----
----
----
79.86%-500K
----
----
----
----
-103.60%-2.48M
--0
Proceeds from stock option exercised by employees
--11.99K
--0
--54.72K
--0
--0
--0
--0
--0
114.73%299.79K
--0
Cash from discontinued financing activities
Financing cash flow
--11.99K
--0
--54.72K
77.09%-500K
---500K
--0
--0
--0
-103.44%-2.18M
--0
Net cash flow
Beginning cash position
-55.20%12.98M
-44.40%18.36M
-41.88%21.94M
-28.14%37.74M
-35.75%25.57M
-34.03%28.96M
-30.03%33.02M
-28.14%37.74M
173.15%52.52M
-28.51%39.8M
Current changes in cash
-44.66%-4.89M
-33.18%-5.39M
24.33%-3.57M
-6.81%-15.78M
-75.66%-3.63M
17.80%-3.38M
-24.27%-4.05M
11.54%-4.72M
-144.36%-14.77M
34.32%-2.07M
Effect of exchange rate changes
232.09%16.17K
276.19%11.32K
-97.27%-9.83K
-168.33%-28.46K
-148.61%-4.81K
-260.04%-12.24K
78.89%-6.43K
-318.74%-4.98K
-1,091.31%-10.61K
825.33%9.9K
End cash Position
-68.31%8.1M
-55.20%12.98M
-44.40%18.36M
-41.88%21.94M
-41.88%21.94M
-35.75%25.57M
-34.03%28.96M
-30.03%33.02M
-28.14%37.74M
-28.14%37.74M
Free cash flow
-54.42%-5.59M
-44.63%-5.19M
18.46%-3.07M
-12.27%-14.37M
-26.71%-3.39M
10.58%-3.62M
-30.77%-3.59M
-13.17%-3.77M
-20.63%-12.8M
-31.23%-2.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -54.54%-5.58M-44.51%-5.19M18.33%-3.07M-12.37%-14.35M-26.85%-3.39M10.55%-3.61M-31.45%-3.59M-12.90%-3.76M-20.54%-12.77M-30.89%-2.67M
Net income from continuing operations -42.52%-4.51M-4.49%-4.96M-40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M
Operating gains losses -184.03%-79.8K-259.88%-56.58K31.66%100.27K-32.09%127.34K-66.63%-79.17K-22.38%94.96K-73.75%35.39K444.43%76.15K272.83%187.52K-6,671.09%-47.51K
Depreciation and amortization 18.27%4.39K21.28%4.26K18.81%4.06K44.98%14.62K44.02%3.98K25.92%3.71K47.21%3.51K71.85%3.42K49.11%10.08K38.62%2.76K
Other non cash items 9.73%43.47K4.38%42.01K2.65%41.08K10.81%160.23K11.60%40.34K9.58%39.61K11.34%40.25K10.72%40.03K59.50%144.6K-47.69%36.15K
Change In working capital -17.19%-914.35K-144.40%-301.64K986.56%2.13M187.93%538.02K131.17%879.22K67.15%-780.24K-39.32%679.39K-191.16%-240.35K-201.98%-611.86K-61.08%380.34K
-Change in prepaid assets 523.89%168.21K-271.55%-913.95K865.92%901.02K191.06%941.44K-31.22%499.36K113.63%26.96K147.49%532.75K73.27%-117.64K-5.01%-1.03M247.92%726.03K
-Change in payables and accrued expense -34.57%-1.03M269.22%661.18K1,988.12%1.27M-140.70%-236.18K237.39%419.92K64.08%-767.87K-92.15%179.07K-109.06%-67.3K-64.22%580.36K-120.54%-305.64K
-Change in other current assets ---4.72K-186.56%-6.15K--0---7.98K--0--0--7.1K---15.08K--0--0
-Change in other current liabilities -13.17%-44.51K-8.08%-42.73K-1.38%-40.89K-0.54%-159.26K-0.02%-40.06K1.81%-39.33K0.16%-39.54K-4.22%-40.33K-121.06%-158.4K44.11%-40.05K
Cash from discontinued investing activities
Operating cash flow -54.54%-5.58M-44.51%-5.19M18.33%-3.07M-12.37%-14.35M-26.85%-3.39M10.55%-3.61M-31.45%-3.59M-12.90%-3.76M-20.54%-12.77M-30.89%-2.67M
Investing cash flow
Cash flow from continuing investing activities 193.60%680.35K55.81%-202.06K42.12%-556.17K-618.89%-930.21K-57.51%256.18K411.61%231.73K13.03%-457.24K-644.35%-960.88K100.92%179.27K357.68%602.86K
Net PPE purchase and sale 36.61%-3.03K---4.27K75.02%-2.22K32.72%-18.73K26.94%-5.08K28.82%-4.78K--0---8.88K-79.65%-27.84K-695,400.00%-6.96K
Net investment purchase and sale 188.95%683.37K56.74%-197.8K41.81%-553.95K-540.09%-911.48K-57.16%261.26K449.59%236.51K10.62%-457.24K-639.32%-952K101.06%207.11K360.65%609.82K
Cash from discontinued investing activities
Investing cash flow 193.60%680.35K55.81%-202.06K42.12%-556.17K-618.89%-930.21K-57.51%256.18K411.61%231.73K13.03%-457.24K-644.35%-960.88K100.92%179.27K357.68%602.86K
Financing cash flow
Cash flow from continuing financing activities 11.99K054.72K77.09%-500K-500K000-103.44%-2.18M0
Net common stock issuance ------------79.86%-500K-----------------103.60%-2.48M--0
Proceeds from stock option exercised by employees --11.99K--0--54.72K--0--0--0--0--0114.73%299.79K--0
Cash from discontinued financing activities
Financing cash flow --11.99K--0--54.72K77.09%-500K---500K--0--0--0-103.44%-2.18M--0
Net cash flow
Beginning cash position -55.20%12.98M-44.40%18.36M-41.88%21.94M-28.14%37.74M-35.75%25.57M-34.03%28.96M-30.03%33.02M-28.14%37.74M173.15%52.52M-28.51%39.8M
Current changes in cash -44.66%-4.89M-33.18%-5.39M24.33%-3.57M-6.81%-15.78M-75.66%-3.63M17.80%-3.38M-24.27%-4.05M11.54%-4.72M-144.36%-14.77M34.32%-2.07M
Effect of exchange rate changes 232.09%16.17K276.19%11.32K-97.27%-9.83K-168.33%-28.46K-148.61%-4.81K-260.04%-12.24K78.89%-6.43K-318.74%-4.98K-1,091.31%-10.61K825.33%9.9K
End cash Position -68.31%8.1M-55.20%12.98M-44.40%18.36M-41.88%21.94M-41.88%21.94M-35.75%25.57M-34.03%28.96M-30.03%33.02M-28.14%37.74M-28.14%37.74M
Free cash flow -54.42%-5.59M-44.63%-5.19M18.46%-3.07M-12.27%-14.37M-26.71%-3.39M10.58%-3.62M-30.77%-3.59M-13.17%-3.77M-20.63%-12.8M-31.23%-2.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.97%
Tesla
TSLA
+3.91%
Disney
DIS
+2.24%
Apple
AAPL
+1.91%
Netflix
NFLX
+1.82%

Unlock the Full List